Similar articles for PMID: 29467954

Year	Number of Results
2009	3
2010	3
2011	3
2012	5
2013	3
2014	5
2015	6
2016	9
2017	14
2018	12
2019	16
2020	14
2021	16
2022	11
2023	10
2024	1

1

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis.

Guo JC, Zheng Y, Chen HT, Zhou H, Huang XH, Zhong LP, Zhou HB, Huang Y, Xie DL, Lou YL. Guo JC, et al. Oncotarget. 2017 Dec 19;9(6):7112-7125. doi: 10.18632/oncotarget.23487. eCollection 2018 Jan 23. Oncotarget. 2017. PMID: 29467954 Free PMC article.

2

Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis.

Li T, Liu Q, Pu T, Liu J, Zhang A. Li T, et al. Expert Opin Pharmacother. 2023 Apr;24(6):763-774. doi: 10.1080/14656566.2023.2198089. Epub 2023 Apr 6. Expert Opin Pharmacother. 2023. PMID: 37010022

3

TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.

Zeng Y, Duan X, Xu J, Ni X. Zeng Y, et al. Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD008235. doi: 10.1002/14651858.CD008235.pub2. Cochrane Database Syst Rev. 2011. PMID: 21735426 Free PMC article. Review.

4

Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis.

Zhang J, Liang Y, Ai Y, Li X, Xie J, Li Y, Zheng W, He R. Zhang J, et al. Sci Rep. 2018 Jan 12;8(1):576. doi: 10.1038/s41598-017-19099-8. Sci Rep. 2018. PMID: 29330464 Free PMC article. Review.

5

Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.

Zhang J, Liang Y, Ai Y, Xie J, Li Y, Zheng W. Zhang J, et al. Expert Opin Pharmacother. 2017 Oct;18(15):1543-1551. doi: 10.1080/14656566.2017.1373091. Epub 2017 Sep 4. Expert Opin Pharmacother. 2017. PMID: 28845713 Review.

6

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review.

Birocchi S, Podda GM, Manzoni M, Casazza G, Cattaneo M. Birocchi S, et al. Platelets. 2021 Feb 17;32(2):216-226. doi: 10.1080/09537104.2020.1745168. Epub 2020 Apr 12. Platelets. 2021. PMID: 32281449

7

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.

Zhang X, Chuai Y, Nie W, Wang A, Dai G. Zhang X, et al. Cochrane Database Syst Rev. 2017 Nov 27;11(11):CD012035. doi: 10.1002/14651858.CD012035.pub2. Cochrane Database Syst Rev. 2017. PMID: 29178132 Free PMC article. Review.

8

Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Dodillet H, Kreuzer KA, Monsef I, Skoetz N. Dodillet H, et al. Cochrane Database Syst Rev. 2017 Sep 30;9(9):CD009883. doi: 10.1002/14651858.CD009883.pub2. Cochrane Database Syst Rev. 2017. PMID: 28962071 Free PMC article. Review.

9

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.

Desborough M, Hadjinicolaou AV, Chaimani A, Trivella M, Vyas P, Doree C, Hopewell S, Stanworth SJ, Estcourt LJ. Desborough M, et al. Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD012055. doi: 10.1002/14651858.CD012055.pub2. Cochrane Database Syst Rev. 2016. PMID: 27797129 Free PMC article. Review.

10

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis.

Tumaini Massaro J, Chen Y, Ke Z. Tumaini Massaro J, et al. Platelets. 2019;30(7):828-835. doi: 10.1080/09537104.2019.1572873. Epub 2019 Feb 27. Platelets. 2019. PMID: 30810479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year